At Galaxy
Therapeutics, we
are inspired by the
intersection of
nature and
medicine to
pioneer
transformative
solutions for
the treatment of brain
aneurysms.
The SEAL Embolization Device is not approved for sale or distribution in Europe or the US and is limited by European and U.S. law to investigational use. Please read IFU before use and for additional info on indications, contraindications, warnings, and precautions.
High density mesh promotes faster
early thrombosis¹.
Fits a broad range of
aneurysm morphologies.
Oversize² with confidence for
ultimate conformability.
No lead-in marker band for
fast, easy placement.
Treat 2.5 – 19mm
aneurysms with just 7 sizes.
For quick, easy placement.
1. Bench testing. Results may vary and may not necessarily be indicative of clinical performance. Testing by: Z Vardar, RM King, A Kraitem, ET Langan, LM Peterson, BH Duncan, C Raskett, V Anagnostakou, MJ Gounis, AS Puri, and GJ Ughi. High Resolution Image-Guided WEB Aneurysm Embolization by High Frequency Optical Coherence Tomography. J Neurointerv Surg 2021; 13(7):669-67 PMID: 32989033.
2. As compared to the WEB device. Data on file.
3. See instructions for use for sizing recommendations.
Galaxy Therapeutics is a clinical-phase startup founded and led by a group of seasoned neurointerventionalists dedicated to streamlining intrasaccular flow diversion. Supported by a team of accomplished engineers and neurovascular experts, we relentlessly pursue the transformation of patients’ lives.
Galaxy Therapeutics, INC.
799 Ames Avenue
Milpitas, CA 95035
Email: [email protected]
